Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia

Patnaik, MM; Sallman, DA; Mangaonkar, AA; Heuer, R; Hirvela, J; Zblewski, D; Al-Kali, A; Binder, M; Balasis, ME; Newman, H; Letson, C; Kruer, TL; Gangat, N; Komrokji, RS; Tefferi, A; Lo, A; Shih, T; Durrant, C; List, AF; Padron, E

Padron, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, 12902 Magnolia Dr, Tampa, FL 33612 USA.

BLOOD, 2020; 136 (7): 909

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索